221 related articles for article (PubMed ID: 28299285)
1. A Genetic Screen Reveals Novel Targets to Render
Lee KM; Lee K; Go J; Park IH; Shin JS; Choi JY; Kim HJ; Yoon SS
Front Cell Infect Microbiol; 2017; 7():59. PubMed ID: 28299285
[No Abstract] [Full Text] [Related]
2. A novel siderophore system is essential for the growth of Pseudomonas aeruginosa in airway mucus.
Gi M; Lee KM; Kim SC; Yoon JH; Yoon SS; Choi JY
Sci Rep; 2015 Oct; 5():14644. PubMed ID: 26446565
[TBL] [Abstract][Full Text] [Related]
3. Novel drug targets in cell wall biosynthesis exploited by gene disruption in Pseudomonas aeruginosa.
Elamin AA; Steinicke S; Oehlmann W; Braun Y; Wanas H; Shuralev EA; Huck C; Maringer M; Rohde M; Singh M
PLoS One; 2017; 12(10):e0186801. PubMed ID: 29045498
[TBL] [Abstract][Full Text] [Related]
4. Identification of essential genes of Pseudomonas aeruginosa for its growth in airway mucus.
Alrahman MA; Yoon SS
J Microbiol; 2017 Jan; 55(1):68-74. PubMed ID: 28035597
[TBL] [Abstract][Full Text] [Related]
5. Integrated whole-genome screening for Pseudomonas aeruginosa virulence genes using multiple disease models reveals that pathogenicity is host specific.
Dubern JF; Cigana C; De Simone M; Lazenby J; Juhas M; Schwager S; Bianconi I; Döring G; Eberl L; Williams P; Bragonzi A; Cámara M
Environ Microbiol; 2015 Nov; 17(11):4379-93. PubMed ID: 25845292
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall-Targeting Immunity.
Torrens G; Sánchez-Diener I; Jordana-Lluch E; Barceló IM; Zamorano L; Juan C; Oliver A
J Infect Dis; 2019 Oct; 220(11):1729-1737. PubMed ID: 31325363
[TBL] [Abstract][Full Text] [Related]
7. NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target.
Fenn S; Dubern JF; Cigana C; De Simone M; Lazenby J; Juhas M; Schwager S; Bianconi I; Döring G; Elmsley J; Eberl L; Williams P; Bragonzi A; Cámara M
mBio; 2021 Apr; 12(2):. PubMed ID: 33879591
[TBL] [Abstract][Full Text] [Related]
8. The intrinsic resistome of Pseudomonas aeruginosa to β-lactams.
Alvarez-Ortega C; Wiegand I; Olivares J; Hancock RE; Martínez JL
Virulence; 2011; 2(2):144-6. PubMed ID: 21304266
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa.
Bala A; Chhibber S; Harjai K
Int J Med Microbiol; 2014 Nov; 304(8):1199-208. PubMed ID: 25240873
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors.
Tan MW; Rahme LG; Sternberg JA; Tompkins RG; Ausubel FM
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2408-13. PubMed ID: 10051655
[TBL] [Abstract][Full Text] [Related]
11. Pleiotropic effects of temperature-regulated 2-OH-lauroytransferase (PA0011) on Pseudomonas aeruginosa antibiotic resistance, virulence and type III secretion system.
Wang B; Li B; Liang Y; Li J; Gao L; Chen L; Duan K; Shen L
Microb Pathog; 2016 Feb; 91():5-17. PubMed ID: 26596709
[TBL] [Abstract][Full Text] [Related]
12. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
[TBL] [Abstract][Full Text] [Related]
13. Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection.
Teneback CC; Scanlon TC; Wargo MJ; Bement JL; Griswold KE; Leclair LW
Antimicrob Agents Chemother; 2013 Nov; 57(11):5559-64. PubMed ID: 23979752
[TBL] [Abstract][Full Text] [Related]
14. Identification of MupP as a New Peptidoglycan Recycling Factor and Antibiotic Resistance Determinant in
Fumeaux C; Bernhardt TG
mBio; 2017 Mar; 8(2):. PubMed ID: 28351916
[TBL] [Abstract][Full Text] [Related]
15. Bacterial killing is enhanced by exogenous administration of lysozyme in the lungs.
Epaud R; Delestrain C; Weaver TE; Akinbi HT
Respir Med Res; 2019 Nov; 76():22-27. PubMed ID: 31505323
[TBL] [Abstract][Full Text] [Related]
16. Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.
Cabassi CS; Sala A; Santospirito D; Alborali GL; Carretto E; Ghibaudo G; Taddei S
Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):17. PubMed ID: 28335779
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.
Lamers RP; Burrows LL
Future Med Chem; 2016 Jun; 8(9):975-92. PubMed ID: 27228070
[TBL] [Abstract][Full Text] [Related]
18. Impact of FiuA Outer Membrane Receptor Polymorphism on the Resistance of
Latino L; Patin D; Chérier D; Touzé T; Pourcel C; Barreteau H; Mengin-Lecreulx D
J Bacteriol; 2019 Jul; 201(13):. PubMed ID: 30988031
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel gene related to antibiotic susceptibility in Pseudomonas aeruginosa.
Shen L; Ma Y; Liang H
J Antibiot (Tokyo); 2012 Feb; 65(2):59-65. PubMed ID: 22146126
[TBL] [Abstract][Full Text] [Related]
20. In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets.
Potvin E; Lehoux DE; Kukavica-Ibrulj I; Richard KL; Sanschagrin F; Lau GW; Levesque RC
Environ Microbiol; 2003 Dec; 5(12):1294-308. PubMed ID: 14641575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
